Study Finds Marketplace Silver Plans Offer Poor Access to HIV Drugs
Michelle Andrews, Kaiser Health News; Posted Nov 23, 9:40 p.m. ET
In most states, consumers with HIV who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs, according to a new analysis.
Taking Darunavir/Cobicistat With Novel Attachment Inhibitor BMS-663068 Is Safe
Mark Mascolini, TheBodyPRO.com; Posted Nov 23, 2:43 p.m. ET
Taking darunavir/cobicistat (Prezcobix) with a new HIV drug known as BMS-663068, which is currently being studied, was safe and did not cause any serious reactions in two studies.
In Charlie Sheen Reporting, Media Chooses Snark, Speculation and Stigma
Althea Fung, TheBody.com; Posted Nov 23, 2:03 p.m. ET
From gay media to mainstream news, the coverage of Charlie Sheen's HIV disclosure has offered many examples of what not to do in ethical and accurate HIV reporting.
Innocent or Unsavory?: Women, HIV and the Charlie Sheen Media Storm
Jennifer Johnson Avril, TheBody.com; Posted Nov 21, 3:09 p.m. ET
"Women who come forward as former partners have some chance of retaining innocent victim status. Those who don't risk scorn as unknowns who somehow deserve HIV, with sex workers in an acute place of blame," says Jennifer Johnson Avril.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
Smokers With HIV More Likely to Get Lung Cancer Than Smokers Without HIV
The Center for AIDS; Posted Nov 20, 10:25 p.m. ET
HIV-positive smokers who had previous lung disease got lung cancer at a 3.5 times higher rate than HIV-negative smokers, according to findings in two large U.S. studies. Smoking more cigarettes, older age, and less education further raised the risk of lung cancer.
Smoking Accounts for More Heart Attacks in People With Than Without HIV
The Center for AIDS; Posted Nov 20, 10:23 p.m. ET
Smoking cigarettes explained almost three out of four heart attacks among HIV-positive people, compared with only one out of four heart attacks in the general population, according to results of a nationwide study in Denmark.
This Week in HIV Research: Cognitive Deficits; Vitamin D Deficiency; and Average Age of HIV Deaths
Warren Tong, TheBodyPRO.com; Posted Nov 20, 11:35 a.m. ET
This week, a study reports that older individuals living with HIV who scored normally based on standard brain psychology tests had cognitive deficits that were revealed by brain scans. Another study looks at vitamin D deficiency and how it may lower immune recovery of people living with HIV.
Meeting the Needs of Transgender People in San Francisco: A Clinician's Perspective
Emily Newman, BETA; Posted Nov 19, 3:55 p.m. ET
Individuals who identify as transgender often are confronted with insurance restrictions, safety concerns and psychosocial barriers in order to access medically necessary gender dysphoria health care services.
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
Is Dolutegravir Alone Enough to Control HIV?
Liz Highleyman, BETA; Posted Nov 19, 3:51 p.m. ET
Dolutegravir (Tivicay, DTG) may be able to suppress HIV when used with just one other well-tolerated drug, and may be able to keep viral load undetectable when used alone, according to studies presented at EACS 2015.
Diagnosing Bed Bugs: A San Francisco HIV Clinical Dermatologist Dispenses Advice
Emily Newman, BETA; Posted Nov 19, 3:47 p.m. ET
In San Francisco, Erin Amerson, M.D., has seen evidence of a bed bug epidemic. Many of her HIV patients live in densely populated areas of the city and in large apartment complexes. "Once one apartment has bed bugs, the whole building has it," Amerson says.
A Prominent Role for Innate Immunity in Eradicating HIV
Jeffrey Laurence, M.D., amfAR, The Foundation for AIDS Research; Posted Nov 19, 3:03 p.m. ET
Most studies for eradicating hidden HIV -- the major obstacle to a cure -- suggest that a treatment approach alone will not be enough. An HIV-positive person's immune system must be stimulated to play an active role as well.
HIV Drug Resistance Study Highlights Need for Viral Load Tests, Affordable Second-Line Treatments
Antigone Barton, Science Speaks; Posted Nov 19, 2:39 p.m. ET
Before treatment even began, more than 5% of people living with HIV in southern Africa had viruses that were resistant to at least one of the first line of HIV drugs, which called for a switch to a second, less accessible and more expensive treatment.
>> Browse Older Featured Stories